Merck & Co.

MRKleader

Merck is a global pharmaceutical giant anchored by Keytruda, the world's best-selling drug, with strong franchises in oncology, vaccines, and animal health.

⇄ Compare

Products & Revenue

Product Revenue Share

Revenue Breakdown ($60.1B)

Static data (loading live financials…)

Oncology (45%)

Vaccines (18%)

Hospital & Specialty (14%)

Animal Health (12%)

Other Pharma (11%)

Segment Breakdown & Key Customers

Product Details

Keytruda42%

World's top-selling drug — PD-1 immune checkpoint inhibitor for oncology

Gardasil / Vaccines14%

HPV vaccine and other prophylactic vaccines

Lagevrio & Antivirals8%

COVID-19 antiviral and legacy antiviral portfolio

Animal Health (Organon split)10%

Livestock and companion animal vaccines and pharmaceuticals

Supply Chain Relationships

Competitors

Pfizer Inc.

Oncology and vaccines

Impact: High — direct competitor in multiple therapeutic areas

Eli Lilly and Company

Oncology pipeline

Impact: Medium — growing oncology rival

Key Customers

Walgreens Boots Alliance

Prescription drug retail

Impact: Medium — pharmacy distribution channel

Partners

Organon & Co.

Legacy women's health portfolio spin-off

Impact: Low — Organon spin-off relationship

Macro & Market Context

제약 / 바이오Sector News

GLP-1 메가트렌드 + AI 신약개발 + 저평가 바이오 기관 매집

GLP-1 시장 규모 (2030E)

$150B

mRNA 암백신 임상 성공률

+49% 재발 위험 감소

AI 신약개발 단계

임상 2상 진입

PFE/MRNA 52주 변화

-30% ~ -45%

Upcoming Catalysts

◆LLY Orforglipron(경구용 GLP-1) 3상 결과 (2026.Q2)◆MRNA 암백신 FDA BLA 제출 예정◆REGN EYLEA HD 유럽 허가 결과

Latest News

Loading news...

AI Analysis

Click "Get AI Analysis" for an AI-powered supply chain analysis of Merck & Co..

Company Info

Headquarters

Rahway, New Jersey, USA

Founded

1891

Employees

69,000+

Website

merck.com

Sector Overview — 제약 / 바이오

Sector News